drugset
drugset / Trial / NCT05787509

Prolonged Progesterone to Prevent Preterm Birth From IVF - ET

NCT05787509 ↗

Phase 4 Recruiting 100 enrolled Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
RandomizedParallel-groupOpen-labelPrevention

Summary

To investigate the incidence of preterm birth in IVF fresh embryo transplantation cycle patients after prolonged vaginal progesterone treatment

Timeline

Start
2023-04-01
Primary completion
2029-04-30
Completion
2029-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Progesterone Other / unclassified 90 mg Intravenous

Indications

No indication recorded.